W. R. Gammon, An in Vitro Model of Immune Complex-mediated Basement Membrane Zone Separation Caused by Pemphigoid Antibodies, Leukocytes, and Complement, Journal of Investigative Dermatology, vol.78, issue.4, pp.285-290, 1982.
DOI : 10.1111/1523-1747.ep12507222

E. Schmidt, K. Obe, E. B. Bröcker, and D. Zillikens, Serum Levels of Autoantibodies to BP180 Correlate With Disease Activity in Patients With Bullous Pemphigoid, Archives of Dermatology, vol.136, issue.2, pp.174-178, 2000.
DOI : 10.1001/archderm.136.2.174

P. Bernard, C. Bedane, and J. M. Bonnetblanc, Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients, British Journal of Dermatology, vol.92, issue.5, pp.694-698, 1997.
DOI : 10.1111/j.1365-2133.1991.tb14794.x

P. Joly, Incidence and Mortality of Bullous Pemphigoid in France, Journal of Investigative Dermatology, vol.132, issue.8, 1998.
DOI : 10.1038/jid.2012.35
URL : https://hal.archives-ouvertes.fr/hal-00729013

P. Bernard, Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group, Archives of Dermatology, vol.131, issue.1, pp.48-52, 1995.
DOI : 10.1001/archderm.131.1.48

P. Joly, A Comparison of Oral and Topical Corticosteroids in Patients with Bullous Pemphigoid, New England Journal of Medicine, vol.346, issue.5, pp.321-327, 2002.
DOI : 10.1056/NEJMoa011592

P. Joly, A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized Study, Journal of Investigative Dermatology, vol.129, issue.7, pp.1681-1687, 2009.
DOI : 10.1038/jid.2008.412
URL : https://hal.archives-ouvertes.fr/hal-00396990

F. Fichel, Clinical and Immunologic Factors Associated With Bullous Pemphigoid Relapse During the First Year of Treatment, JAMA Dermatology, vol.150, issue.1, pp.25-33, 2014.
DOI : 10.1001/jamadermatol.2013.5757

L. Jan and S. , Innate Immune Cell???Produced IL-17 Sustains Inflammation in Bullous Pemphigoid, Journal of Investigative Dermatology, vol.134, issue.12, pp.2908-2917, 2014.
DOI : 10.1038/jid.2014.263

J. Plée, Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Scientific Reports, vol.134, issue.1, p.18001, 2015.
DOI : 10.1001/archderm.134.9.1075

L. Leighty, N. Li, L. A. Diaz, and Z. Liu, Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid, Archives of Dermatological Research, vol.127, issue.9, pp.417-422, 2007.
DOI : 10.4049/jimmunol.177.5.3398

Z. Liu, Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model, Journal of Autoimmunity, vol.31, issue.4, pp.331-338, 2008.
DOI : 10.1016/j.jaut.2008.08.009

K. N. Messingham, Eosinophil localization to the basement membrane zone is autoantibody- and complement-dependent in a human cryosection model of bullous pemphigoid, Experimental Dermatology, vol.97, issue.1, pp.50-55, 2016.
DOI : 10.1016/0008-8749(86)90400-4

L. Dubertret, B. Bertaux, M. Fosse, and R. Touraine, Cellular events leading to blister formation in bullous pemphigoid, British Journal of Dermatology, vol.24, issue.6, pp.615-624, 1980.
DOI : 10.1111/1523-1747.ep12544448

S. P. Hogan, Eosinophils: Biological Properties and Role in Health and Disease, Clinical & Experimental Allergy, vol.11, issue.4, pp.709-750, 2008.
DOI : 10.1067/mai.2003.139

G. M. Walsh, Eosinophil granule proteins and their role in disease, Current Opinion in Hematology, vol.8, issue.1, pp.28-33, 2001.
DOI : 10.1097/00062752-200101000-00006

K. R. Acharya and S. J. Ackerman, Eosinophil Granule Proteins: Form and Function, Journal of Biological Chemistry, vol.259, issue.25, pp.17406-17415, 2014.
DOI : 10.1021/pr050341h
URL : http://www.jbc.org/content/289/25/17406.full.pdf

V. S. Muniz, P. F. Weller, and J. S. Neves, Eosinophil crystalloid granules: structure, function, and beyond, Journal of Leukocyte Biology, vol.365, issue.2, pp.281-288, 2012.
DOI : 10.1056/NEJMc1103005
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395420/pdf

L. Borrego, Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins, Am. J. Pathol, vol.148, pp.897-909, 1996.

M. Inaoki and K. Takehara, Increased serum levels of interleukin (IL)-5, IL-6 and IL-8 in bullous pemphigoid, Journal of Dermatological Science, vol.16, issue.2, pp.152-157, 1998.
DOI : 10.1016/S0923-1811(97)00044-3

D. 'auria and L. , IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severity, Arch. Dermatol. Res, vol.290, pp.25-27, 1998.

S. Karlen, Biological and Molecular Characteristics of Interleukin-5 and its Receptor, International Reviews of Immunology, vol.11, issue.1, pp.227-247, 1998.
DOI : 10.1073/pnas.88.24.11349

L. Büdinger, Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls., Journal of Clinical Investigation, vol.102, issue.12, pp.2082-2089, 1998.
DOI : 10.1172/JCI3335

A. Mishra, S. P. Hogan, J. J. Lee, P. S. Foster, and M. E. Rothenberg, Fundamental signals that regulate eosinophil homing to the gastrointestinal tract, Journal of Clinical Investigation, vol.103, issue.12, pp.1719-1727, 1999.
DOI : 10.1172/JCI6560
URL : http://www.jci.org/articles/view/6560/files/pdf

H. Long, W. Liao, L. Wang, and Q. Lu, A Player and Coordinator: The Versatile Roles of Eosinophils in the Immune System, Transfusion Medicine and Hemotherapy, vol.43, issue.2, pp.96-108, 2016.
DOI : 10.1159/000445215

R. Venge, Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.73, issue.6, pp.1172-1186, 1999.
DOI : 10.1136/adc.73.5.413

D. A. Plager, Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity, The Journal of Immunology, vol.183, issue.6, pp.4013-4020, 1950.
DOI : 10.4049/jimmunol.0900055
URL : http://www.jimmunol.org/content/jimmunol/183/6/4013.full.pdf

M. Tomassini, Release of granule proteins by eosinophils from allergic and nonallergic patients with eosinophilia on immunoglobulin-dependent activation, Journal of Allergy and Clinical Immunology, vol.88, issue.3, pp.365-375, 1991.
DOI : 10.1016/0091-6749(91)90099-A

, Scientific RepoRts | 7: 4833 | DOI:10

W. Czech, J. Schaller, E. Schöpf, and A. Kapp, Granulocyte activation in bullous diseases: Release of granular proteins in bullous pemphigoid and pemphigus vulgaris, Journal of the American Academy of Dermatology, vol.29, issue.2, pp.210-215, 1993.
DOI : 10.1016/0190-9622(93)70170-X

M. Riani, Bullous pemphigoid outcome is associated with CXCL10-induced matrix metalloproteinase 9 secretion from monocytes and neutrophils but not lymphocytes, Journal of Allergy and Clinical Immunology, vol.139, issue.3, p.12, 2016.
DOI : 10.1016/j.jaci.2016.08.012
URL : https://hal.archives-ouvertes.fr/hal-01754072

L. Vaillant, Evaluation of Clinical Criteria for Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.134, issue.9, pp.1075-1080, 1998.
DOI : 10.1001/archderm.134.9.1075

P. Bernard, Recommandations des centres de r??f??rence des maladies bulleuses auto-immunes pour le diagnostic et la prise en charge de la pemphigo??de bulleuse, Annales de Dermatologie et de V??n??r??ologie, vol.138, issue.3, pp.247-251, 2011.
DOI : 10.1016/j.annder.2011.01.009